首页> 美国卫生研究院文献>The Journal of Neuroscience >The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation Synaptic Decay Neuronal Loss and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy
【2h】

The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation Synaptic Decay Neuronal Loss and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy

机译:Tau蛋白重复域中β结构的潜力决定了Tauopathy诱导型小鼠模型中的聚集突触衰变神经元丢失以及与内源性Tau的共组装

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe two new transgenic mouse lines for studying pathological changes of Tau protein related to Alzheimer's disease. They are based on the regulatable expression of the four-repeat domain of human Tau carrying the FTDP17 (frontotemporal dementia and parkinsonism linked to chromosome 17) mutation ΔK280 (TauRD/ΔK280), or the ΔK280 plus two proline mutations in the hexapeptide motifs (TauRD/ΔK280/I277P/I308P). The ΔK280 mutation accelerates aggregation (“proaggregation mutant”), whereas the proline mutations inhibit Tau aggregation in vitro and in cell models (“antiaggregation mutant”). The inducible transgene expression was driven by the forebrain-specific CaMKIIα (calcium/calmodulin-dependent protein kinase IIα) promoter. The proaggregation mutant leads to Tau aggregates and tangles as early as 2–3 months after gene expression, even at low expression (70% of endogenous mouse Tau). The antiaggregation mutant does not aggregate even after 22 months of gene expression. Both mutants show missorting of Tau in the somatodendritic compartment and hyperphosphorylation in the repeat domain [KXGS motifs, targets of the kinase MARK (microtubule affinity regulating kinase)]. This indicates that these changes are related to Tau expression rather than aggregation. The proaggregation mutant causes astrogliosis, loss of synapses and neurons from 5 months of gene expression onward, arguing that Tau toxicity is related to aggregation. Remarkably, the human proaggregation mutant TauRD coaggregates with mouse Tau, coupled with missorting and hyperphosphorylation at multiple sites. When expression of proaggregation TauRD is switched off, soluble and aggregated exogenous TauRD disappears within 1.5 months. However, tangles of mouse Tau, hyperphosphorylation, and missorting remain, suggesting an extended lifetime of aggregated wild-type Tau once a pathological conformation and aggregation is induced by a proaggregation Tau species.
机译:我们描述了两种新的转基因小鼠系,用于研究与阿尔茨海默氏病有关的Tau蛋白的病理变化。它们基于人类Tau的四重复结构域的可调节表达,该结构带有FTDP17(额颞痴呆和帕金森病,与17号染色​​体相关)突变ΔK280(TauRD /ΔK280),或ΔK280加上六肽基序(TauRD)中的两个脯氨酸突变/ΔK280/ I277P / I308P)。 ΔK280突变加速聚集(“聚集突变体”),而脯氨酸突变在体外和细胞模型中抑制Tau聚集(“抗聚集突变体”)。诱导型转基因表达是由前脑特异性CaMKIIα(钙/钙调蛋白依赖性蛋白激酶IIα)启动子驱动的。早在基因表达后2-3个月,即使在低表达时(70%的内源性小鼠Tau),该聚集突变体也会导致Tau聚集和缠结。即使在基因表达22个月后,抗聚集突变体也不会聚集。两种突变体都显示出Tau在体树突状区室中的缺失和重复结构域中的高磷酸化[KXGS基序,MARK激酶(微管亲和力调节激酶)的靶标]。这表明这些变化与Tau表达有关,而不是与聚集有关。从基因表达的5个月起,这种聚集突变体会引起星形胶质细胞增多症,突触和神经元的丢失,并认为Tau毒性与聚集有关。值得注意的是,人类聚集突变体TauRD与小鼠Tau聚集在一起,并在多个位点发生错配和超磷酸化。当关闭聚集TauRD的表达时,可溶性和聚集的外源TauRD在1.5个月内消失。但是,小鼠Tau的缠结,过度磷酸化和错漏仍然存在,这表明一旦聚集的Tau物种诱发了病理构象和聚集,聚集的野生型Tau的寿命就会延长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号